Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Magnetic Fields for Treatment of Parkinson's Disease
This study has been completed.
First Received: October 22, 2008   Last Updated: March 17, 2009   History of Changes
Sponsored by: pico-tesla Magnetic Therapies, LLC
Information provided by: pico-tesla Magnetic Therapies, LLC
ClinicalTrials.gov Identifier: NCT00779155
  Purpose

The purpose of this study is to determine if low level magnetic fields may help to relieve symptoms of Parkinson's disease.


Condition Intervention
Parkinson's Disease
Device: Jacobson Resonator
Device: Placebo

Genetics Home Reference related topics: familial paroxysmal nonkinesigenic dyskinesia Parkinson disease
MedlinePlus related topics: Parkinson's Disease
U.S. FDA Resources
Study Type: Interventional
Official Title: A Double-Blind, Sham-Stimulation Controlled Study of the Application of Magnetic Fields Using the Jacobson Resonator for the Treatment of Parkinson's Disease.

Further study details as provided by pico-tesla Magnetic Therapies, LLC:

Primary Outcome Measures:
  • Change from baseline to study end point in the combined scores from the UPDRS subscale II and III recorded in the subjects "on" state. [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]

Arms Assigned Interventions
A: Placebo Comparator Device: Placebo
comparison of active magnetic field therapy with placebo fields
B: Active Comparator Device: Jacobson Resonator
comparison of active magnetic field therapy with placebo fields

  Eligibility

Ages Eligible for Study:   30 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • idiopathic PD with motor fluctuations of at least 3-4 hours daily., Subject on levodopa, subject is ambulatory, maintain regular med schedule, willing and able to abstain from new PD treatments, Able to demonstrate correct completion of PD diaries, non-demented, adequate contraceptive measures, capable of giving full written consent.

Exclusion Criteria:

  • any factors that will prevent subject from completing full course of therapy with the resonator, any factors preventing subject from attending clinic in the "off" state, atypical parkinsonism, no active brain tumors, strokes, hydrocephalus, any other neurologic or non-neurologic disorder which might affect the symptomatic expression of pts. parkinsonism, suffers from chronic pain, no meds that may produce parkinsonism, no psychiatric disturbance, Epilepsy, HIV, Cancer, History of ECT, Diabetic Neuropathy, Uncontrolled HTN, Advanced Pulmonary Disease, Known heart conditions such as cardiac arrythmias, previous PD surgical interventions, prosthetics comprised of ferrous metals, pacemakers, DBS, Uncontrolled, unstable or untreated medical illnesses, Consumption of more than 21 alcoholic drinks per week, Pregnant, breast feeding, developmental disability
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00779155

Locations
United States, Colorado
pico-tesla Magnetic Therapies
Littleton, Colorado, United States, 80120
Sponsors and Collaborators
pico-tesla Magnetic Therapies, LLC
  More Information

No publications provided

Responsible Party: pico-tesla Magnetic Therapies, LLC ( pico-tesla Magnetic Therapies, LLC )
Study ID Numbers: PD pilot 2
Study First Received: October 22, 2008
Last Updated: March 17, 2009
ClinicalTrials.gov Identifier: NCT00779155     History of Changes
Health Authority: United States: Institutional Review Board

Study placed in the following topic categories:
Ganglion Cysts
Movement Disorders
Parkinson Disease
Basal Ganglia Diseases
Central Nervous System Diseases
Parkinsonian Disorders
Neurodegenerative Diseases
Brain Diseases

Additional relevant MeSH terms:
Movement Disorders
Parkinson Disease
Nervous System Diseases
Basal Ganglia Diseases
Central Nervous System Diseases
Parkinsonian Disorders
Neurodegenerative Diseases
Brain Diseases

ClinicalTrials.gov processed this record on May 07, 2009